Kleiner Perkins × OpenEvidence: AI Engineers at the Frontier

​Kleiner Perkins and OpenEvidence are hosting an evening for engineers building at the frontier of AI. Join OpenEvidence's Chief Scientist and SVP of ML, alongside investment partners from Kleiner Perkins, for sunset drinks, bites, and a candid conversation on what's actually working at the frontier.

OpenEvidence is the most widely-used medical AI system among U.S. doctors, processing over 1 million clinical consultations a day. Founded with the mission to organize and expand global medical knowledge, the majority of U.S. physicians use OpenEvidence daily to make high-stakes clinical decisions at the point of care that are sourced, cited, and grounded in peer-reviewed medical literature.

For five decades, Kleiner Perkins has partnered with intrepid founders to build iconic companies that made history. Today, Kleiner Perkins continues that legacy, investing in founders with bold ideas that span industries and continents, partnering with them from inception to IPO and beyond to maximize the potential of their ideas and make history across consumer, enterprise, health care, financial services, and hardtech.